CEO Barry Biffle stated, "We delivered third quarter results per share at the midpoint of our guidance range, demonstrating disciplined execution as we navigated competitive fare pressures and excess ...

Mitchell provided guidance for Q3, expecting "adjusted loss between $0.26 and $0.42 per share and fuel at an expected average all-in cost of $2.51 per gallon." Nonfuel costs are to include transition ...

It’s a story about love, friendship, and the pain of broken promises. Three close friends find their lives changed after one unexpected incident. Can love survive when everything falls apart?

It’s a story about love, friendship, and the pain of broken promises. Three close friends find their lives changed after one unexpected incident. Can love survive when everything falls apart?

In Sarasota and Manatee, the work of REALTORS® is often associated with listings and home sales. Beyond the transaction, the REALTOR® Association of Sarasota and Manatee (RASM) plays a critical role ...

Recent data from the Realtors Association of Sarasota and Manatee (RASM) confirms what real-estate agents on the ground, like Angie Ramos, are already seeing: more listings, fewer sales and a growing ...

Unit Revenue Improvement: Fourth quarter unit revenues increased by 8% year-over-year. RASM Growth: Fourth quarter RASM was up 8% year-over-year, exceeding prior guidance. CASM-X Increase: Fourth ...

At the end of 2024, the real estate market in Sarasota and Manatee counties showed signs of stabilization after the frenzy of the pandemic years. The newly released Year-End 2024 Market Report from ...

Sarasota-Manatee's real estate market showed "a clear slowdown, with fewer sales, lower prices and longer times to sell" in November, according to the monthly report from the Realtors Association of ...

UBS is starting coverage on many U.S. airlines, highlighting the relevance of supply and demand dynamics in driving RASM growth and margin performance until 2025. Driven by increasing RASMs and ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. TipRanks is the most comprehensive data set of sell side analysts ...

Positive preliminary Phase 1b SEACRAFT-1 data for naporafenib plus trametinib reinforce therapeutic potential in NRASm melanoma and further support ongoing Phase 3 SEACRAFT-2 trial SEACRAFT-2 has ...